Get the Stockscreener App
1.95
0.00%
0.00
After Hours:
1.85
-0.10
-5.13%
180 Life Sciences Corp stock is traded at $1.95, with a volume of 50,622.
It is up +0.00% in the last 24 hours and up +12.72% over the past month.
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.
See More
Previous Close:
$1.95
Open:
$1.86
24h Volume:
50,622
Relative Volume:
0.09
Market Cap:
$1.89M
Revenue:
-
Net Income/Loss:
$-19.94M
P/E Ratio:
-0.0814
EPS:
-23.95
Net Cash Flow:
$-10.92M
1W Performance:
+7.73%
1M Performance:
+12.72%
6M Performance:
-47.30%
1Y Performance:
-83.77%
1-Day Range:
$1.79
$2.05
1-Week Range:
$1.66
$2.65
52-Week Range:
$1.31
$15.72
180 Life Sciences Corp Stock (ATNF) Company Profile
Name
180 Life Sciences Corp
Sector
Industry
Phone
650-507-0669
Address
3000 EL CAMINO REAL, PALO ALTO
180 Life Sciences Corp Stock (ATNF) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-15-21 | Initiated | Maxim Group | Buy |
180 Life Sciences Corp Stock (ATNF) Latest News
Biopharma Layoff Tracker 2024: Connect Biopharma, BioMarin and More Cut Staff - BioSpace
ATNF’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - The InvestChronicle
Why Modular Medical Shares Are Trading Higher By Around 29%; Here Are 20 Stocks Moving Premarket - Benzinga
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.09% - Mitrade
Zydus Lifesciences Shares Surge 4% on USFDA Final Approval - EquityPandit
Assenagon Asset Management S.A. Decreases Stock Position in Illumina, Inc. (NASDAQ:ILMN) - Defense World
180 Life Sciences (NASDAQ:ATNF) Stock Quotes, Forecast and News Summary - Benzinga
NIH grants funds to Boston Immune’s Phase I trial of TNFR2 antagonist - Clinical Trials Arena
ATNF (180 Life Sciences) 3-Year EPS without NRI Growth Rate : 41.70% (As of Jun. 2024) - GuruFocus.com
HTGMQ (HTG Molecular Diagnostics) Float Percentage Of Total Shares Outstanding : 99.92% (As of Aug. 18, 2024) - GuruFocus.com
Baker Tilly Wealth Management LLC Has $236,000 Holdings in Illumina, Inc. (NASDAQ:ILMN) - Defense World
ATNF (180 Life Sciences) EV-to-Revenue : (As of Aug. 17, 2024) - GuruFocus.com
Q3 2024 EPS Estimates for Edwards Lifesciences Co. (NYSE:EW) Decreased by Zacks Research - Defense World
SELLAS Life Sciences Group (NASDAQ:SLS) Issues Quarterly Earnings Results - Defense World
Kezar Life Sciences, Inc. (NASDAQ:KZR) to Post Q3 2024 Earnings of ($0.30) Per Share, William Blair Forecasts - Defense World
HC Wainwright Reiterates Buy Rating for Kezar Life Sciences (NASDAQ:KZR) - Defense World
Art’s-Way Manufacturing Co., Inc. (NASDAQ:ARTW) Short Interest Down 61.5% in July - Defense World
Algoma Steel Group Inc. (NASDAQ:ASTLW) Short Interest Update - Defense World
180 Life Sciences Corp. (NASDAQ:ATNF) Short Interest Update - Defense World
Life Science Tools Market Advancements Highlighted by Detailed Analysis with Accurate Forecast to 2031. - WhaTech
Is Wall Street Bullish Or Bearish On Edwards Lifesciences Stock? - Barchart
Greenwich LifeSciences CEO and CFO Patel Snehal buys $27,620 in company stock - Investing.com
Valneva Scotland Receives Prestigious Award for Health and Safety Excellence - PharmiWeb.com
ENDRA Life Sciences (NDRA) Set to Announce Quarterly Earnings on Wednesday - Defense World
Life science credit company Symbiotic Capital launches with $600m - Medical Device Network
NGK Insulators (OTCMKTS:NGKIF) Trading Down 7.3% - Defense World
180 Life Sciences (NASDAQ:ATNF) Trading Down 6.2% - Defense World
Comerica Bank Has $4.70 Million Stake in Mesa Laboratories, Inc. (NASDAQ:MLAB) - Defense World
B. Riley Wealth Advisors Inc. Has $377,000 Holdings in Invesco S&P 500 High Dividend Low Volatility ETF (NYSEARCA:SPHD) - Defense World
Abacus Life (ABL) Set to Announce Quarterly Earnings on Monday - Defense World
180 Life Sciences reports CBD pill outperforms liquid in study - Investing.com
180 Life Sciences reports CBD pill outperforms liquid in study - Investing.com India
ATNF180 Life Sciences Corp. Latest Stock News & Market Updates - StockTitan
Anavex Life Sciences: Short-Lived Spike On Latest Alzheimer's Data Not Surprising (AVXL) - Seeking Alpha
Chandan Taparia's recommendations: How to trade Zydus Lifesciences, Federal Bank, IOC shares on July 26? | Stock Market News - Mint
180 Life Sciences Granted an Additional Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements - StockTitan
Abrdn Life Sciences Investors (NYSE:HQL) Shares Purchased by Oppenheimer & Co. Inc. - Defense World
Abrdn Life Sciences Investors (NYSE:HQL) Director Rose Dimartino Acquires 1,000 Shares of Stock - Defense World
ENDRA Life Sciences faces Nasdaq delisting over low share price - Investing.com
180 Life Sciences Corp. (NASDAQ:ATNF) Short Interest Up 13.2% in June - Defense World
Nuvectra (OTCMKTS:NVTRQ) Stock Price Passes Below 50-Day Moving Average of $0.02 - Defense World
Short Interest in Haidilao International Holding Ltd. (OTCMKTS:HDALF) Rises By 16.1% - Defense World
Swiss National Bank Has $17.71 Million Stock Position in Donaldson Company, Inc. (NYSE:DCI) - Defense World
RLI Corp. (NYSE:RLI) Holdings Lifted by BNP Paribas Financial Markets - Defense World
Edwards Lifesciences buys mitral valve business Innovalve in $300m deal - Medical Device Network
Scotiabank lifts Lithium Americas Corp [NewCo] [LAC] price estimate. Who else is bullish? - The DBT News
Wolfe Research slashes price target on Roivant Sciences Ltd [ROIV] – find out why. - The DBT News
Barclays lifts NatWest Group Plc ADR [NWG] price estimate. Who else is bullish? - The DBT News
How Many Stocks Are There in 2024? - Benzinga
What You Need To Know Ahead Of Edwards Lifesciences' Earnings Release - Barchart
NASDAQ – Stock Price, Charts & News Today - BNN Bloomberg
180 Life Sciences Corp Stock (ATNF) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):